213 related articles for article (PubMed ID: 3024542)
1. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation.
Winston DJ; Ho WG; Lin CH; Bartoni K; Budinger MD; Gale RP; Champlin RE
Ann Intern Med; 1987 Jan; 106(1):12-8. PubMed ID: 3024542
[TBL] [Abstract][Full Text] [Related]
2. [Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation].
Winston DJ; Ho WG; Lin GH; Bartoni K; Budinger MD; Gale RP; Champlin RE
Immun Infekt; 1985 Nov; 13(6):296-301. PubMed ID: 3000923
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus immune plasma in bone marrow transplant recipients.
Winston DJ; Pollard RB; Ho WG; Gallagher JG; Rasmussen LE; Huang SN; Lin CH; Gossett TG; Merigan TC; Gale RP
Ann Intern Med; 1982 Jul; 97(1):11-8. PubMed ID: 6283982
[TBL] [Abstract][Full Text] [Related]
4. [Cytomegalovirus hyperimmune globulin prophylaxis in bone marrow transplants in children with various diseases].
Ebell W; Blütters-Sawatzki R; Friedrich W; Hampl W; Kleihauer E
Immun Infekt; 1985 Nov; 13(6):307-12. PubMed ID: 3000925
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial.
Winston DJ; Ho WG; Lin CH; Budinger MD; Champlin RE; Gale RP
Am J Med; 1984 Mar; 76(3A):128-33. PubMed ID: 6324586
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
Condie RM; O'Reilly RJ
Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
[No Abstract] [Full Text] [Related]
7. Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients.
Condie RM; O'Reilly RJ
Am J Med; 1984 Mar; 76(3A):134-41. PubMed ID: 6324587
[TBL] [Abstract][Full Text] [Related]
8. Acute graft-vs.-host disease and interstitial pneumonitis interrelated problems following allogeneic bone marrow transplantation: effects of intravenous immune globulin and other interventions.
Champlin RE; Ho WG; Winston DJ
J Hosp Infect; 1988 Aug; 12 Suppl D():29-33. PubMed ID: 2902126
[No Abstract] [Full Text] [Related]
9. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
Snydman DR; Werner BG; Heinze-Lacey B; Berardi VP; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS
N Engl J Med; 1987 Oct; 317(17):1049-54. PubMed ID: 2821397
[TBL] [Abstract][Full Text] [Related]
10. Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation.
Jacobsen N; Schäfer U; Ostendorf P; Kubaneck B; Wolf H
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):193-5. PubMed ID: 3010510
[TBL] [Abstract][Full Text] [Related]
11. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.
Meyers JD; Leszczynski J; Zaia JA; Flournoy N; Newton B; Snydman DR; Wright GG; Levin MJ; Thomas ED
Ann Intern Med; 1983 Apr; 98(4):442-6. PubMed ID: 6301320
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
[TBL] [Abstract][Full Text] [Related]
13. Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
Guglielmo BJ; Wong-Beringer A; Linker CA
Bone Marrow Transplant; 1994 May; 13(5):499-510. PubMed ID: 8054903
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.
Sullivan KM; Kopecky KJ; Jocom J; Fisher L; Buckner CD; Meyers JD; Counts GW; Bowden RA; Peterson FB; Witherspoon RP
N Engl J Med; 1990 Sep; 323(11):705-12. PubMed ID: 2167452
[TBL] [Abstract][Full Text] [Related]
15. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
[No Abstract] [Full Text] [Related]
16. Use of intravenous immune globulin in patients receiving bone marrow transplants.
Winston DJ; Ho WG; Rasmussen LE; Lin CH; Chu HL; Merigan TC; Gale RP
J Clin Immunol; 1982 Apr; 2(2 Suppl):42S-47S. PubMed ID: 6282926
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin.
Emanuel D; Cunningham I; Jules-Elysee K; Brochstein JA; Kernan NA; Laver J; Stover D; White DA; Fels A; Polsky B
Ann Intern Med; 1988 Nov; 109(10):777-82. PubMed ID: 2847609
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.
Schmidt GM; Horak DA; Niland JC; Duncan SR; Forman SJ; Zaia JA
N Engl J Med; 1991 Apr; 324(15):1005-11. PubMed ID: 1848679
[TBL] [Abstract][Full Text] [Related]
19. Successful strategy for prevention of cytomegalovirus interstitial pneumonia after human leukocyte antigen-identical bone marrow transplantation.
Elfenbein GJ; Siddiqui T; Rand KH; Graham-Pole J; Marcus RB; Mendenhall NP; Goedert TM; Wikle-Fisher T; Gross SA; Weiner RS
Rev Infect Dis; 1990; 12 Suppl 7():S805-10. PubMed ID: 2173109
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and biological evaluation of the preventive role of anti-cytomegalovirus specific immunoglobulins in bone marrow grafts. Randomized study of 60 patients].
Bordigoni P; Janot C; Aymard JP; Witz F; Bené MC; Legras B; Schoonemann F; Olive D; Streiff F
Nouv Rev Fr Hematol (1978); 1987; 29(5):289-93. PubMed ID: 2830588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
